GOVX GeoVax Labs, Inc.

GeoVax Labs, Inc. is a clinical-stage biotechnology company with a robust pipeline of human vaccines and immunotherapies to address unmet medical needs in cancer and infectious disease.

$5.14
As of 06/24/2021     IEX book   CBOE book

---

Security Information

---

Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  
IPO date:  12/31/1997
Outstanding shares:  6,327,702
Average volume:  287,429
Market cap:   $32,271,280
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    
ISIN:        
Sedol:      

---

Valuation   (See tab for details)

---

PE ratio:   -8.21
PB ratio:   1.69
PS ratio:   0.00
Return on equity:   0.00%
Net income %:   0.00%